Roberts Brandi
- SEC CIK
- 0001516354
In the past year, 2 open-market sale filings worth $259.2K and no purchases.
Current role at each company
- DFTX Definium Therapeutics, Inc.Chief Financial Officeras of Sep 29, 2026
- LBPH Longboard Pharmaceuticals, Inc.Executive VP and CFOas of Dec 2, 2024
- TFFP TFF Pharmaceuticals, Inc.Directoras of Jul 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $259.2K
- 2 filings
- Net
- −$259.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Roberts Brandi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DFTX Definium Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 (view filing)9:08 PM ET | Sep 25 | 4 days | Roberts BrandiChief Financial Officer | SSale | −3.38K | $36.57 | −$123.5K | −0.8%394.5K after | 10b5-1 |
| Jun 26, 2026 (view filing) | Jun 25 | 1 day | Roberts BrandiChief Financial Officer | SSale | −3.01K | $45.03 | −$135.7K | −1.4%209.5K after | 10b5-1 |
TFFP TFF Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Roberts BrandiDirector | PPurchase | +20.0K | $0.25 | +$5.00K | New position20.0K after |